Citation Impact
Citing Papers
Pten Deficiency in Melanocytes Results in Resistance to Hair Graying and Susceptibility to Carcinogen-Induced Melanomagenesis
2008 StandoutNobel
Final Version of 2009 AJCC Melanoma Staging and Classification
2009 Standout
Similar Nucleotide Excision Repair Capacity in Melanocytes and Melanoma Cells
2010 StandoutNobel
Primary Cutaneous Follicular Lymphoma
2001
Myeloid-Derived Suppressor Cells: Linking Inflammation and Cancer
2009 Standout
Pancreatic cancer
2004 Standout
Cellular and Gene Expression Responses Involved in the Rapid Growth Inhibition of Human Cancer Cells by RNA Interference-mediated Depletion of Telomerase RNA
2005 StandoutNobel
Stromal fibroblasts in cancer initiation and progression
2004 StandoutNature
Psoriasis
2009 Standout
Immunosuppressive networks in the tumour environment and their therapeutic relevance
2005 Standout
Integrins in cancer: biological implications and therapeutic opportunities
2009 Standout
Ido expression by dendritic cells: tolerance and tryptophan catabolism
2004 Standout
Pathogenesis and clinical features of psoriasis
2007 Standout
Melanin Pigmentation in Mammalian Skin and Its Hormonal Regulation
2004 Standout
Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes
2002 Standout
Active immunization against cancer with dendritic cells: The near future
2001 StandoutNobel
Biomarkers in melanoma: predisposition, screening and diagnosis
2003
TGF-β signaling in tumor suppression and cancer progression
2001 Standout
Cutaneous Follicle Center Lymphoma: A Clinicopathologic Study of 19 Cases
2001
The αvintegrin antagonists as novel anticancer agents: an update
2002
Dissemination and growth of cancer cells in metastatic sites
2002 Standout
BRAFE600-associated senescence-like cell cycle arrest of human naevi
2005 StandoutNature
Primary Cutaneous Follicular Lymphoma
2002
Cancer immunotherapy: breaking the barriers to harvest the crop
2004 StandoutNobel
Die Therapie der primären kutanen B-Zell-Lymphome
2000
Coordinated regulation of myeloid cells by tumours
2012 Standout
WHO-EORTC classification for cutaneous lymphomas
2005 Standout
Evidence for a tumoral immune resistance mechanism based on tryptophan degradation by indoleamine 2,3-dioxygenase
2003 Standout
Suppression of Melanoma Cell Proliferation by Histidine Decarboxylase Specific Antisense Oligonucleotides
2001
Primary Cutaneous Marginal Zone B-Cell Lymphoma: A Recently Described Entity of Low-Grade Malignant Cutaneous B-Cell Lymphoma
1997
Myeloid-derived suppressor cells as regulators of the immune system
2009 Standout
Synthetic organic dyes as contaminants of the aquatic environment and their implications for ecosystems: A review
2020 Standout
Autocrine TGF-?-regulated expression of adhesion receptors and integrin-linked kinase in HT-144 melanoma cells correlates with their metastatic phenotype
1999
Enhancement of the anti-tumor immune response using a combination of interferon-γ and B7 expression in an experimental mammary carcinoma
1998 StandoutNobel
Prevalence of Joint Disease in Patients with Psoriasis
2003
Common and unique mechanisms regulate fibrosis in various fibroproliferative diseases
2007 Standout
Cancer immunotherapy: moving beyond current vaccines
2004 Standout
Immunohistochemical characteristics of melanoma
2008
Distinct Sets of Genetic Alterations in Melanoma
2005 Standout
Translation of new cancer treatments from pet dogs to humans
2008 Standout
In situ expression of B7 and CD28 receptor families in human malignant melanoma: Relevance for T‐cell‐mediated anti‐tumor immunity
1995
Proliferative activity of primary cutaneous melanocytic tumours
1993
Short Telomeres are Sufficient to Cause the Degenerative Defects Associated with Aging
2009 StandoutNobel
Cutaneous Manifestations of Lymphoma: A Clinical Guide Based on the WHO Classification
2001
Molecular prognostic markers in intermediate-thickness cutaneous malignant melanoma
1999
MALT and SALT: the clue to cutaneous B-cell lymphoproliferative disease
2006
AUTOCRINE AND PARACRINE REGULATION BY CYTOKINES AND GROWTH FACTORS IN MELANOMA
2000
Comparative Histopathology of Grey‐Horse‐Melanoma and Human Malignant Melanoma
2004
Malignant melanoma: modern black plague and genetic black box
1998
Radiotherapy of cutaneous B cell lymphomas: Our experience in 31 cases
1993
Primary, Adaptive, and Acquired Resistance to Cancer Immunotherapy
2017 Standout
T Cell Surveillance of Oncogene-Induced Prostate Cancer Is Impeded by T Cell-Derived TGF-β1 Cytokine
2011 StandoutNobel
Regulation of type I interferon responses
2013 Standout
A Role for T Helper 2 Cells in Mediating Skin Fibrosis in Tight-Skin Mice
1999
The STATs of cancer — new molecular targets come of age
2004 Standout
Inflammatory signaling compromises cell responses to interferon alpha
2011
Regulatory T cells in tumor immunity
2010 StandoutNobel
IFNγ and lymphocytes prevent primary tumour development and shape tumour immunogenicity
2001 StandoutNature
Primary cutaneous melanoma. Optimized cutoff points of tumor thickness and importance of clark's level for prognostic classification
1995
Cancer and the chemokine network
2004 Standout
Antigen-processing machinery breakdown and tumor growth
2000
Interleukin-8 and human cancer biology
2001
Malignant melanoma: genetics and therapeutics in the genomic era
2006
Primary cutaneous B-cell lymphoma: A unique type of low-grade lymphoma. Clinicopathologic and immunologic study of 83 cases
1991
The Immunobiology of Cancer Immunosurveillance and Immunoediting
2004 Standout
NF-κB: linking inflammation and immunity to cancer development and progression
2005 Standout
Escape of Human Solid Tumors from T–Cell Recognition: Molecular Mechanisms and Functional Significance
1999
Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colony-stimulating factor.
1992 StandoutNobel
Type, Density, and Location of Immune Cells Within Human Colorectal Tumors Predict Clinical Outcome
2006 StandoutScience
General mechanisms of metastasis
1997
The Three Es of Cancer Immunoediting
2004 Standout
Prognostic Factors Analysis of 17,600 Melanoma Patients: Validation of the American Joint Committee on Cancer Melanoma Staging System
2001 Standout
Cyclin D1 is a candidate oncogene in cutaneous melanoma.
2002
Role of Dendritic Cells in Benign and Malignant Lymphocytic Infiltrates of the Skin
1994
Constitutive IkappaB kinase activity correlates with nuclear factor-kappaB activation in human melanoma cells.
2001
Cancer Immunoediting: Integrating Immunity’s Roles in Cancer Suppression and Promotion
2011 StandoutScience
EORTC classification for primary cutaneous lymphomas: a proposal from the Cutaneous Lymphoma Study Group of the European Organization for Research and Treatment of Cancer.
1997 Standout
Cancer in dyskeratosis congenita
2009
Low-Level Monocyte Chemoattractant Protein-1 Stimulation of Monocytes Leads to Tumor Formation in Nontumorigenic Melanoma Cells
2001
Mantle-Cell Lymphomas of the Skin
1994
Primary cutaneous follicle center cell lymphoma with follicular growth pattern
2000
Primary Cutaneous Follicular Lymphoma: An Assessment of Clinical, Histopathologic, Immunophenotypic, and Molecular Features
2002
Reversion of immune tolerance in advanced malignancy: modulation of myeloid-derived suppressor cell development by blockade of stem-cell factor function
2007
Does the Immune System See Tumors as Foreign or Self?
2003
Wound Healing: A Cellular Perspective
2018 Standout
Final Version of the American Joint Committee on Cancer Staging System for Cutaneous Melanoma
2001 Standout
The Life History of Dendritic Leukocytes (DL)
1989
Normalization of Tumor Vasculature: An Emerging Concept in Antiangiogenic Therapy
2005 StandoutScience
TRANSFORMING GROWTH FACTOR-β REGULATION OF IMMUNE RESPONSES
2005 Standout
Primary cutaneous lymphomas: applicability of current classification schemes (European Organization for Research and Treatment of Cancer, World Health Organization) based on clinicopathologic features observed in a large group of patients
2002
Identification of proliferating dendritic cell precursors in mouse blood.
1992 StandoutNobel
Primary Cutaneous Follicular Lymphoma: An Assessment of Clinical, Histopathologic, Immunophenotypic, and Molecular Features
2002
Simultaneous Blockade of Platelet-Derived Growth Factor-Receptor and Epidermal Growth Factor-Receptor Signaling and Systemic Administration of Paclitaxel as Therapy for Human Prostate Cancer Metastasis in Bone of Nude Mice
2004
Works of Silvia Moretti being referenced
Interdigitating reticulum cells in the dermal infiltrate of mycosis fungoides
1988
Stem cell factor affects tumour progression markers in metastatic melanoma cells
2006
Primary Cutaneous Follicular Center Cell Lymphoma: Clinical and Histological Aspects
2015
Correlation of Ki-67 expression in cutaneous primary melanoma with prognosis in a prospective study: Different correlation according to thickness
2001
Increasing Epidermal Growth Factor Receptor Expression in Human Melanocytic Tumor Progression
1992
In situ expression of transforming growth factor ?? is associated with melanoma progression and correlates with Ki67, HLA-DR and ?? 3 integrin expression
1997
Oral carcinoma in a young man: a case of dyskeratosis congenita
2000
Ki67 Antigen Expression Correlates with Tumor Progression and HLA-DR Antigen Expression in Melanocytic Lesions
1990
Efficacy of Rhodamine Light in the Treatment of Superficial Vascular Lesions of the Face
2016
Immunohistochemical evidence of cytokine networks during progression of human melanocytic lesions
1999
Primary cutaneous follicular centre-cell lymphoma-a lymphoproliferative disease with favourable prognosis
1989
Fibrogenic cytokines in vulvar lichen sclerosus. An immunohistochemical study.
1997
Phenotypic profile of major synovial cell populations in longstanding psoriatic arthritis.
1987
Dendritic cells in the dermal infiltrate of Sézary syndrome
1986
Adhesion molecule profile and malignancy of melanocytic lesions.
1993
BANS
1992